Table 3.
Impact of preoperative variables on the length of stay. Preoperative variables were included in univariate analysis if significant in Table 1, Table 2 and Table 3 and N > 9. Variables were included in the multivariate model if p < 0.2 for univariate analysis.
Variable | Univariate | Multivariate | ||
---|---|---|---|---|
RR (CI) | p-Value | aRR (CI) | p-Value | |
Malnourished | 5.09 (3.36–6.81) | <0.001 * | 3.49 (1.97–5.02) | <0.001 * |
Age | −0.03 (−0.09–0.03) | 0.264 | −0.01 (−0.06–0.04) | 0.740 |
Female | −0.10 (−1.65–1.46) | 0.904 | −0.16 (−1.55–1.23) | 0.820 |
Race | ||||
NHW | −1.47 (−2.97–0.03) | 0.055 | REF | REF |
NHB | 1.61 (−0.37–3.58) | 0.110 | 1.39 (−0.61–3.39) | 0.173 |
Hispanic | 0.66 (−1.83–3.15) | 0.604 | 0.34 (−2.17–2.85) | 0.793 |
Asian | 1.63 (−1.42–4.68) | 0.295 | 1.54 (−1.56–4.64) | 0.330 |
AIAN | −5.07 (−18.92–8.79) | 0.473 | −3.93 (−17.67–9.80) | 0.574 |
NHOPI | −2.40 (−14.40–9.61) | 0.695 | −0.70 (−12.61–11.21) | 0.908 |
BMI | −0.05 (−0.17–0.07) | 0.413 | - | - |
ASA (1–2) | −2.57 (−4.80–−0.35) | 0.024 * | REF | REF |
ASA (3–4) | 2.57 (0.35–4.80) | 0.024 * | 1.56 (−0.46–3.58) | 0.130 |
Electrolyte abnormality | 1.50 (−0.49–3.48) | 0.139 | 0.03 (−1.69–1.75) | 0.971 |
Emergency case | −0.83 (−2.82–1.15) | 0.411 | - | - |
Smoking | −0.86 (−2.76–1.04) | 0.374 | - | - |
Dyspnea | 0.69 (−2.31–3.69) | 0.652 | - | - |
Dependent functional status | −0.51 (−3.04–2.01) | 0.690 | - | - |
Bleeding disorder | 2.59 (−0.61–5.80) | 0.112 | 1.79 (−0.91–4.49) | 0.194 |
Anemic | 2.22 (0.63–3.80) | 0.006 * | 1.10 (−0.36–2.55) | 0.139 |
RBC transfusion day of surgery |
3.01 (1.26–4.76) | 0.001 * | 2.06 (0.54–3.59) | 0.008 * |
RR: relative risk; CI: 95% confidence interval; aRR: adjusted relative risk; NHW: non-Hispanic white; NHB: non-Hispanic black; AIAN: American Indian or Alaska native; NHOPI: native Hawaiian or Pacific islander; BMI: body mass index; ASA: American Society of Anesthesiologists classification; RBC: red blood cell. * statistically significant.